This page is historical material reflecting the Feedback Loop Blog as it existed on July 23, 2020. This page is no longer updated and links to external websites and some internal pages may not work.
July 23, 2020

Archived: Remembering Ward Smith

Headshot of Ward Smith. Credit: NIGMS.

I am deeply saddened to tell you that Ward Smith, chief of our Biomedical Technology Branch in the Division of Biophysics, Biomedical Technology, and Computational Biology, passed away at the beginning of July.

Ward first joined NIGMS in 2007 as a program director in our former Division of Cell Biology and Biophysics. Among his major contributions to NIGMS were his management of the Protein Structure Initiative, for which he was honored with an NIH Director’s Award, and of the NIH-supported synchrotron facilities. Ward also oversaw a large portfolio of grants in biomedical technology. The recipient of several NIGMS awards, he was a well-liked colleague who was generous with his time and willingness to help others. 

Prior to coming to NIGMS, Ward had an illustrious career in academia and industry. After receiving his Ph.D. at the University of Michigan, where he worked in the lab with Martha Ludwig, he joined David Eisenberg’s lab at the University of California, Los Angeles, where he conducted structural studies on ribulose-1,5-biphosphate carboxylase/oxygenase, a photosynthetic enzyme essential to the global carbon cycle. He went on to spend most of his career in industry where he applied his crystallography expertise and served in leadership positions. Major contributions included crystallizing the enzyme that’s the target of glyphosate (an active ingredient in weedkillers) and solving the structure of thymidylate synthase with 5-fluorouracil, one of the first examples of the structure of a drug bound to its target. Other work helped launch the paradigm of structure-based drug design.

We will miss Ward greatly.


About the Author

Judith Greenberg

Judith Greenberg

Before her retirement in October 2020, Judith was the deputy director of NIGMS and the acting director of the Division of Biophysics, Biomedical Technology, and Computational Biosciences. In the past, she also served as the acting director of the Institute and as the director of the former Division of Genetics and Developmental Biology. She led the development of the NIGMS strategic plan issued in 2008 and the development and implementation of the NIGMS strategic plan for training issued in 2011.